期刊文献+

肥大细胞类胰蛋白酶(MCT)在口腔鳞癌患者血清中表达水平的研究 被引量:3

Studies on the Expression Level of Mast Cell Tryptase(MCT)in Serum of Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:通过对比检测口腔鳞癌患者、良性颌面部肿瘤患者及健康对照者血清中的肥大细胞类胰蛋白酶(MCT)的表达水平,分析其在口腔鳞癌患者血清的表达水平有无异常,并分析其潜在的临床意义。方法:收集63例口腔鳞癌患者、47例颌面良性肿瘤患者及55例健康对照者的血清,用ELISA试剂盒检测血清中MCT的表达水平,后分析口腔鳞癌患者血清中MCT水平的临床意义。结果:口腔鳞癌患者血清中的MCT的表达水平高于其它两组,但不具有显著的统计学差异(P=0.09),而在口腔鳞癌组,MCT的浓度水平与肿瘤的大小呈正性相关,此外,在中分化鳞癌中MCT的表达水平相对较高。结论:MCT作为肥大细胞聚集、活化的标记物之一,在口腔鳞癌患者血清的表达并未显著升高,而血清MCT的表达水平与肿瘤大小有关。 Objective:To detect the expression level of mast cell tryptase(MCT)in serum of oral squamous cell carcinoma,benign maxillofacial cancer and healthy controls,and analyse its potential clinical significance in patients with OSCC.Methods:The serums from 63 case of OSCC,47 cases with maxillofacial benign tumor and 55 healthy controls were collected,and the MCT in serum was detected using MCT ELISA kit.Results:The MCT expression level in serum from patient with OSCC was higher than the other two groups,but without significant difference(P=0.09),and in cases with OSCC,MCT concentration levels was positively associated with tumor size,in addition,moderately differentiated OSCC had relatively higher expression levels of MCT.Conclusion:MCT,as an indicator of mast cell aggregation,activation,did not significantly increase in serum from OSCC patients,and the expression level of MCT was associated with tumor size.
出处 《口腔医学研究》 CAS CSCD 2014年第12期1166-1168,共3页 Journal of Oral Science Research
关键词 口腔鳞状细胞癌 肥大细胞类胰蛋白酶(MCT) Oral squamous cell carcinoma Mast cell tryptase(MCT)
  • 相关文献

参考文献10

  • 1李男男,胡敏,王金蕊,周晶,韩光红.口腔鳞状细胞癌中CADM1蛋白的表达及意义[J].口腔医学研究,2011,27(2):145-148. 被引量:3
  • 2Ribatti D, Crivellato E. The controversial role of mast cells in tumor growth [J]. Int Rev Cell Mol Biol, 2009, 275 : 89 --131.
  • 3Norrby K. Mast cells and angiogenesis [J]. APMIS, 2002, 110(5) : 355--371.
  • 4Xiang M, Gu Y, Zhao F, et al. Mast cell tryptase promotes breast cancer migration and invasion [J]. Oncol Rep, 2010, 23(3): 615--619.
  • 5Takanami I, Takeuchi K, Naruke M.. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma [J]. Cancer, 2000, 88(12) : 2686-2692.
  • 6Nechushtan H. The complexity of the complicity of mast cells in cancer [J]. Int J Biochem Cell Biol, 2010, 42(5) : 551--554.
  • 7Valent P, Horny HP, Triggiani M, et al. Clinical and labo ratory parameters of mast cell activation as basis for the for- mulation of diagnostic criteria [J]. Int Arch Allergy Immu- nol, 2011, 156(2) : 119--127.
  • 8Strouch MJ, Cheon EC, Salabat MR, et al. Crosstalk be- tween mast cells and pancreatic cancer cells contributes to pancreatic tumor progression [J].Clin Cancer Res, 2010, 16 (8) : 2257--2265.
  • 9Dabiri S, Huntsman D, Makretsov N, et al. The presence of stromal mast cells identifies a subset of invasive breast canc- ers with a favorable prognosis [J]. Mod Pathol, 2004, 17(6) : 690--695.
  • 10Cheema VS, Ramesh V, Balamurali PD. The relevance of mast cells in oral squamous cell carcinoma [J]. J Clin Diagn Res, 2012, 6(10) : 1803--1807.

二级参考文献13

  • 1Van Heerden WF, Swat TJ, Van Heerden MB,et al. FH IT proteinexpression in oral epithelium: immunohistochemical evaluation of threeantisera [J]. Anticancer Res, 2001, 21(4A) : 2419-2423.
  • 2Masami Kuramochil, Hiroshi Fukuharal, Takahiro Nobukunil, et al. TSLC1 is a tumor-suppressor gene in human non -small-cell lung cancer [J]. Nat Genet, 2001, 27 : 427-430.
  • 3PletcherMT, Nobukuni T, Fukuhara H, et al. Identification of tumor suppressor candidate genes by physical and sequence mapping of the TSLC1 region of human chromosome 11q23[J]. Gene, 2001, 273: 181189.
  • 4Surace EI, Lusis E, Murakami Y, et al. Loss of tumor supp ressor in lung cancer-1 ( TSLC1 ) expression in meningioma correlates with increasedmalignancy grade and reduced patient survival [J]. J Neuropathol Exp Neurol, 2004, 63(10): 1015-1027.
  • 5Uchino K, Ito A, Wakayana T, et al. Clinical in placation and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung [J]. Cancer,2003, 5 : 1002-1007.
  • 6Overmeer RM, Henken FE, Snijders PJ, et al. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC [J].J Pathol, 2008, 215(4) : 388-397.
  • 7Shimizu K, Onishi M, Sugata E, et al. Aberrant DNA methylation of the 5' upstream region of Tslcl gene in hamster pancreatic tumors [J]. Biochem Biophys' Res Commun,2007, 353(2) : 522-526.
  • 8Kitamura Y, Kurosawa G, Tanaka M, et al. Frequent overexpression of CADM1/IGSF4 in lung adenocarcinoma [J].Biochem Biophys Res Commun, 2009, 383(4) : 480-484.
  • 9Dickinson PJ, Surace EI, et al. Expression of the tumor suppressor genes NF2, 4. 1B, and TSLC1 in canine meningiomas [J]. Vet Pathol, 2009, 46(5): 884-92.
  • 10Overmeer RM, Henken FE, Snijders PJ ,et al. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC [J].J Pathol, 2008, 215(4): 388-397.

共引文献2

同被引文献52

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部